271 related articles for article (PubMed ID: 21049556)
1. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
4. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
5. Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene.
Lutz P; Wasmuth JC; Nischalke HD; Vidovic N; Grünhage F; Lammert F; Oldenburg J; Rockstroh JK; Sauerbruch T; Spengler U
Eur J Med Res; 2011 Aug; 16(8):335-41. PubMed ID: 21813376
[TBL] [Abstract][Full Text] [Related]
6. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
Moodie EE; Pant Pai N; Klein MB
PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
[TBL] [Abstract][Full Text] [Related]
7. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
8. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients.
Ajao S; Roach D; Chan KH; Thimmanagari K; Muhanna A; Mutyala M; Lakasanni S; Slim J
Gastroenterology Res; 2021 Aug; 14(4):209-213. PubMed ID: 34527089
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
11. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
12. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
[TBL] [Abstract][Full Text] [Related]
13. Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART.
Grünhage F; Wasmuth JC; Herkenrath S; Vidovic N; Goldmann G; Rockstroh J; Lammert F; Oldenburg J; Sauerbruch T; Spengler U
Eur J Med Res; 2010 Apr; 15(4):139-44. PubMed ID: 20554494
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
Merchante N; Rivero A; de Los Santos-Gil I; Merino D; Márquez M; López-Ruz MA; Rodríguez-Baño J; Del Valle J; Camacho A; Sanz-Sanz J; Macías J; Pérez-Camacho I; Gómez-Mateos J; Moro A; Pineda JA
Gut; 2009 Dec; 58(12):1654-60. PubMed ID: 19625279
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
17. Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry.
Mazzocato S; Orsetti E; Gesuita R; Piraccini F; Drenaggi D; Barchiesi F
Scand J Infect Dis; 2014 Nov; 46(11):797-802. PubMed ID: 25244675
[TBL] [Abstract][Full Text] [Related]
18. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
[TBL] [Abstract][Full Text] [Related]
19. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.
Mariné-Barjoan E; Saint-Paul MC; Pradier C; Chaillou S; Anty R; Michiels JF; Sattonnet C; Ouzan D; Dellamonica P; Tran A;
AIDS; 2004 Nov; 18(16):2163-70. PubMed ID: 15577649
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
